# ARM Holdings plc: Form 20-F for the period ended Mar 31, 2024

- Company: [ARM Holdings plc](/companies/arm.md) (CIK 1973239)
- Form: 20-F
- Filed: 2024-05-29
- Accepted by EDGAR: May 29, 2024, 16:05 ET
- Period: 2024-03-31
- Accession: 0001973239-24-000012
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1973239/000197323924000012/arm-20240331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1973239/000197323924000012/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2023-04-01 to 2024-03-31 | $3.23bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2023-04-01 to 2024-03-31 | $154.0m | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2023-04-01 to 2024-03-31 | $3.08bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2023-04-01 to 2024-03-31 | $1.98bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2023-04-01 to 2024-03-31 | $983.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2023-04-01 to 2024-03-31 | $111.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2023-04-01 to 2024-03-31 | −$93.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2023-04-01 to 2024-03-31 | $306.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2023-04-01 to 2024-03-31 | $0.29 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2023-04-01 to 2024-03-31 | $0.30 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2023-04-01 to 2024-03-31 | 1,044,497,032 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2023-04-01 to 2024-03-31 | $1.09bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2023-04-01 to 2024-03-31 | $92.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2024-03-31 | $1.92bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-03-31 | $4.20bn | us-gaap:AssetsCurrent |
| Total assets | at 2024-03-31 | $7.93bn | us-gaap:Assets |
| Current liabilities | at 2024-03-31 | $1.50bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-03-31 | $2.63bn | us-gaap:Liabilities |
| Shareholders' equity | at 2024-03-31 | $5.29bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2024-03-31 | 1,040,330,497 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1973239/000197323924000012/arm-20240331.htm

Filed May 29, 2024.
Source: SEC EDGAR, the filing index for accession 0001973239-24-000012. Last ingested by Listed: Nov 4, 2026, 16:46 ET. No prices; not investment advice.